has launched Sage Intacct Accountants in Canada. This new programme is designed to provide efficient accounting practices by ...
Sage is in good financial condition. Our model-driven credit risk assessment is low. As of fiscal 2024, the company had a net debt/EBITDA ratio of 1.2 times, which is within Sage's medium term target ...
Sage Therapeutics (NASDAQ:SAGE – Get Free Report) was upgraded by equities research analysts at Royal Bank of Canada from an “underperform” rating to a “sector perform” rating in a research note ...
RBC Capital upgraded Sage Therapeutics (SAGE) to Sector Perform from Underperform with an unchanged price target of $4.Don't Miss our Black ...